LYTGOBI
NDC 64842-0120, FUTIBATINIB, tablet, from TAIHO PHARMACEUTICAL CO., LTD..
- Product NDC
- 64842-0120
- Status
- Listed
- Labeler
- TAIHO PHARMACEUTICAL CO., LTD.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA214801
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64842-0120 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FUTIBATINIB4 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Fibroblast Growth Factor Receptor Inhibitors [MoA]; Kinase Inhibitor [EPC]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64842-0120-4 | 64842012004 | 1 BLISTER PACK in 1 CARTON (64842-0120-4) / 21 TABLET in 1 BLISTER PACK |
| 64842-0120-5 | 64842012005 | 1 BLISTER PACK in 1 CARTON (64842-0120-5) / 28 TABLET in 1 BLISTER PACK |
| 64842-0120-6 | 64842012006 | 1 BLISTER PACK in 1 CARTON (64842-0120-6) / 35 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0b1332a1-0581-4707-9bf6-1eccfa39bef4
Use it
Look up 64842-0120 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64842-0120 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64842-0120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.